Skip to main content
Psychedex

1Provenance card

the boundary, as counts

Sources

2718 with DOI

2 strong · 18 moderate · 7 weak

Compilations

12026-05-11T23:24:11.950Z

pipeline-v5 · prompt hash not recorded — run predates 2026-09

Decisions

43last ruled 2026-06-04

0 awaiting a ruling

Issued documents

42026-10-19T20:32:21.117Z

notice · info card · emergency

Searches

171 with no results

queries and counts on the build

Claims checked

6136 supported

36 supported · 25 not

Correspondence

0received

consent field ships in Phase 4

Edges

222

derivations recorded for this entity

Complete over 27 sources, 1 compilation, and 43 decisions.Not here: the private journal (never).Working material — drafts, discards, unsupported claims — is listed below and readable on the working page.Cite: psychedex.org/substances/isopropylphenidate/archive

Timeline

what happened, newest first — claims, searches and artifacts stay inside Build

  1. 2026-10-19issueIssued info_card
  2. 2026-09-24srcAnalysis of six 'neuro-enhancing' phenidate analogs
  3. 2026-09-24srcEthylphenidate as a selective dopaminergic agonist and methylphenidate-ethanol transesterification biomarker.
  4. 2026-09-24srcDesigner drugs: mechanism of action and adverse effects
  5. 2026-09-24srcOverdose of drugs for attention-deficit hyperactivity disorder: clinical presentation, mechanisms of toxicity, and management.
  6. 2026-09-24srcTramadol: Understanding the Risk of Serotonin Syndrome and Seizures
  7. 2026-09-24srcNo prescription? No problem: A qualitative study investigating self-medication with novel psychoactive substances (NPS)
  8. 2026-09-24srcSeven fatalities associated with ethylphenidate.
  9. 2026-09-24srcIdentification of in vitro metabolites of ethylphenidate by liquid chromatography coupled to quadrupole time-of-flight mass spectrometry
  10. 2026-09-24srcPharmacological profile of methylphenidate-based designer drugs
  11. 2026-09-24srcPharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone or in combination
  12. 2026-09-24srcNemo censetur ignorare legem: what research chemists should know about the EU legal framework
  13. 2026-09-24srcStimulant and hallucinogenic novel psychoactive substances; an update
  14. 2026-09-24srcIsopropylphenidate: an ester homolog of methylphenidate with sustained and selective dopaminergic activity and reduced drug interaction liability
  15. 2026-09-24srcUse of UPLC-HRMS/MS for In Vitro and In Vivo Metabolite Identification of Three Methylphenidate-derived New Psychoactive Substances
  16. 2026-09-24srcDifferential influences of ethanol on early exposure to racemic methylphenidate compared with dexmethylphenidate in humans
  17. 2026-09-24srcUse of cognitive enhancers: methylphenidate and analogs
  18. 2026-09-24srcThe Psychonauts' World of Cognitive Enhancers
  19. 2026-09-24srcNovel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling
  20. 2026-09-24srcSlow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter
  21. 2026-09-24srcTramadol: seizures, serotonin syndrome, and coadministered antidepressants
  22. 2026-09-24srcA comparison of the motor-activating effects of acute and chronic exposure to amphetamine and methylphenidate
  23. 2026-09-24srcUK control of methylphenidate-based NPS: Misuse of Drugs (Amendment) Regulations 2017
  24. 2026-09-24srcGermany NpSG: New Psychoactive Substances Act (Neue-psychoaktive-Stoffe-Gesetz) November 2016
  25. 2026-09-24srcUS Patent US20120245201A1: Isopropylphenidate for Treatment of ADHD and Fatigue-Related Disorders
  26. 2026-09-24srcUNODC Early Warning Advisory: UK temporarily bans five methylphenidate-related NPS (April 2015)
  27. 2026-09-24srcCanada Gazette: Amendments to Controlled Drugs and Substances Act Schedule III (methylphenidate analogues)
  28. 2026-09-24srcUK Temporary Class Drug Order: Methylphenidate-based NPS (ACMD Report, April 2015)
  29. 2026-09-04issueIssued emergency
  30. 2026-09-04issueIssued info_card
  31. 2026-09-04issueIssued notice
  32. 2026-06-04proposal41 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
  33. 2026-06-04publicationPublication — backfill
  34. 2026-05-11revisionRevision 1
  35. 2026-05-11absenceSearched ClinicalTrials.gov for "isopropylphenidate" — no results
  36. 2026-05-11genGeneration — pipeline-v5 · with 2 morepipeline-v5
  37. 2026-05-11rungeneration run

The same entries, as forms: six forms.